FREE SHIPPING ON ORDERS OVER $150

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Dihexa | c-Met chemical |

$29.36

Quantity
- +
Description

There is considerable evidence linking clinical characteristics of type 1 diabetes with cognitive impairment, with age of onset and disease duration being among the most frequently investigated factors

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Dihexa | c-Met chemical |

"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial." Annals of Internal Medicine

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Dihexa | c-Met chemical |

Not for human consumption, therapeutic use, or diagnostic purposes

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Dihexa | c-Met chemical |

Learn More Diabetes Management Ask about our physician-led diabetes and metabolic optimization program

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Dihexa | c-Met chemical |

You may also like

recommand products